Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid

Neurobiology of Disease

Volumn 36, Issue 1, 2009, Pages 213-222

  Mahmoudi, Souha ^a   Samadi, Pershia ^b   Gilbert, François ^b   Ouattara, Bazoumana ^b   Morissette, Marc ^b   Grégoire, Laurent ^b   Rouillard, Claude ^b   Di Paolo, Thérèse ^b   Lévesque, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Basal ganglia; Caudate nucleus; DHA; L Dopa induced dyskinesia (LID); MPTP treated monkey; NGFI B; NR4A1; Parkinson's disease; Putamen; Retinoid X receptor (RXR); Striatum; Substance P

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BENSERAZIDE PLUS LEVODOPA; DOCOSAHEXAENOIC ACID; DOPAMINE; MESSENGER RNA; NUCLEAR RECEPTOR NUR77; RETINOID X RECEPTOR GAMMA; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DENERVATION; DRUG MECHANISM; DYSKINESIA; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RISK REDUCTION;

ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; ANTIPARKINSON AGENTS; AUTORADIOGRAPHY; BRAIN; COCAINE; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; DRUG INTERACTIONS; DYSKINESIA, DRUG-INDUCED; FEMALE; IODINE ISOTOPES; LEVODOPA; MACACA FASCICULARIS; MPTP POISONING; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROTEIN BINDING; RNA, MESSENGER; STATISTICS AS TOPIC;

EID: 69749086620     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.07.017     Document Type: Article

References (43)

1. Andersson M., Hilbertson A., and Cenci M.A. Striatal FosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol. Dis. 6 (1999) 461-474
2. Ballion B., Mallet N., Bezard E., Lanciego J.L., and Gonon F. Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism. Eur. J. Neurosci. 27 (2008) 2313-2321
3. Bassilana F., Mace N., Li Q., Stutzmann J.M., Gross C.E., Pradier L., Benavides J., Ménager J., and Bezard E. Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease. Neurobiol. Dis. 20 (2005) 93-103
4. Beaudry G., Langlois M.C., Weppe I., Rouillard C., and Lévesque D. Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor Nerve Growth Factor-Inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem. 75 (2000) 1694-1702
5. Bédard P.J., Blanchet P.J., Lévesque D., Soghomonian J.J., Grondin R., Morissette M., Goulet M., Calon F., Falardeau P., Gomez-Mancilla B., Doucet J.P., Robertson G.S., and Di Paolo T. Pathophysiology of L-dopa-induced dyskinesias. Mov. Disord. 14 (1999) 4-8
6. Bélanger N., Grégoire L., Tahar A.H., and Bédard P.J. Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys. Mov. Disord. 18 (2003) 1436-1441
7. Brotchie J.M., Lee J., and Venderova K. Levodopa-induced dyskinesia in Parkinson's disease. J. Neural Transm. 112 (2005) 359-391
8. Calabresi P., Di Filippo M., Ghiglieri V., and Picconi B. Molecular mechanisms underlying levodopa-induced dyskinesia. Mov. Disord. 23 Suppl. 3 (2008) S570-S579
9. Calon F., Tahar A.H., Blanchet P.J., Morissette M., Grondin R., Goulet M., Doucet J.P., Robertson G.S., Nestler E., Di Paolo T., and Bédard P.J. Dopamine-receptor stimulation: biobehavioral and biochemical consequences. Trends Neurosci. 23 Suppl. (2000) S92-S100
10. Cenci M.A. Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia. Trends Neurosci. 30 (2007) 236-243
11. Doucet J.P., Nakabeppu Y., Bédard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., and Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of ΔFosB-like protein(s) in both the rodent and primate striatum. Eur. J. Neurosci. 8 (1996) 365-381
12. Ethier I., Beaudry G., St-Hilaire M., Milbrandt J., Rouillard C., and Lévesque D. The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. Neuropsychopharmacology 29 (2004) 335-346
13. Ethier I., Kagechika H., Shudo K., Rouillard C., and Lévesque D. Docosahexaenoic acid reduces haloperidol-induced dyskinesias in mice: involvement of Nur77 and retinoid receptors. Biol. Psychiatry 56 (2004) 522-526
14. Forman B.M., Umesono K., Chen J., and Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81 (1995) 541-550
15. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311 (1984) 461-464
16. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460 (1988) 161-167
17. Gerfen C.R., McGinty J.F., and Young III W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11 (1991) 1016-1031
18. Graybiel A.M., and Ragsdale Jr. C.W. Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 5723-5726
19. Graybiel A.M., Canales J.J., and Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 23 (Suppl.) (2000) S71-S77
20. Guigoni C., Li Q., Aubert I., Dovero S., Bioulac B.H., Bloch B., Crossman A.R., Gross C.E., and Bezard E. Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J. Neurosci. 25 (2005) 2102-2107
21. Haber S.N., Kim K.S., Mailly P., and Calzavara R. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 26 (2006) 8368-8376
22. Henry B., Duty S., Fox S.H., Crossman A.R., and Brotchie J.M. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp. Neurol. 183 (2003) 458-468
23. Hurd Y.L., and Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64 (1995) 571-586
24. Karnovsky M.J., and Roots L. A "direct-coloring" thiocholine method for cholinesterases. J. Histochem. Cytochem. 12 (1964) 219-221
25. Konradi C., Westin J.E., Carta M., Eaton M.E., Kuter K., Dekundy A., Lundblad M., and Cenci M.A. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia. Neurobiol. Dis. 17 (2004) 219-236
26. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., and Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 881-885
27. Langlois M.C., Beaudry G., Zekki H., Rouillard C., and Lévesque D. Impact of antipsychotic drug administration on the expression of nuclear receptors in the neocortex and striatum of the rat brain. Neuroscience 106 (2001) 117-128
28. Lévesque D., and Rouillard C. Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation. Trends Neurosci. 30 (2007) 22-30
29. Maira M., Martens C., Philips A., and Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 19 (1999) 7549-7557
30. Mata de Urquiza A., Liu S., Sjöberg M., Zetterström R.H., Griffiths W., Sjövall J., and Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (2000) 2140-2144
31. Morissette M., Dridi M., Calon F., Tahar A.H., Meltzer L.T., Bédard P.J., and Di Paolo T. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-d-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin. Mov. Disord. 21 (2006) 9-17
32. 1B receptor agonists for the treatment of L-DOPA-induced dyskinesia. Brain 131 (2008) 3380-3394
33. Pavon N., Martin A.B., Mendialdua A., and Moratalla R. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol. Psychiatry 59 (2006) 64-74
34. Paxinos G. The Rhesus Monkey Brain in Stereotaxic Coordinates (2009), Academic Press, Boston
35. Samadi P., Grégoire L., Rouillard C., Di Paolo T., and Lévesque D. Docosahexaenoic acid reduces Levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Annals Neurol. 59 (2006) 282-288
36. Sgambato-Faure V., Buggia V., Gilbert F., Lévesque D., Benabid A.L., and Berger F. Coordinated and spatial upregulation of Arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats. J. Neuropathol. Exp. Neurol. 64 (2005) 936-947
37. St-Hilaire M., Landry É., Lévesque D., and Rouillard C. Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats. Neurobiol. Dis. 14 (2003) 98-109
38. 1-dependent mechanism. Neurobiol. Dis. 20 (2005) 450-460
39. St-Hilaire M., Bourhis E., Lévesque D., and Rouillard C. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77 knockout mice. Eur. J. Neurosci. 24 (2006) 795-805
40. van den Munckhof P., Gilbert F., Chamberland M., Lévesque D., and Drouin J. Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in Aphakia mice, a model of Parkinson's disease. J. Neurochem. 96 (2006) 160-170
41. Xiao Q., Castillo S.O., and Nikodem V.M. Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization. Neuroscience 75 (1996) 221-230
42. Zetterström R.H., Solomin L., Mitsiadis T., Olson L., and Perlmann T. Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1. Mol. Endocrinol. 10 (1996) 1656-1666
43. Zetterström R.H., Williams R., Perlmann T., and Olson L. Cellular expression of the immediate-early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Mol. Brain Res. 41 (1996) 111-120